Until recently, the opportunity to have a celebrity attend an event, attach themselves to a name-brand or endorse a certain product or idea was untouchable. The thought of paying a person to promote a product was seen as something only Fortune 500 companies could afford. Social media has changed all that with brands and businesses utilizing celebrity influencers to connect directly with their demographics and increase sales and profits.
5th International Conference and Exhibition on Pharmaceutical Regulatory Affairs
OMICS Group invites all the participants across the globe to attend the 5th International Conference and Exhibition on Pharmaceutical Regulatory Affairs during August 03-05, 2015 Florida, USA with the theme of Share and Enhance the Aspects on Novel Policies in Regulatory Affairs. Regulatory Affairs 2015 has been exceptionally formulated with novel topics like Best Industry Practices, Regulatory Requirements for Pharmaceuticals, Intellectual Property Management and Novel Strategies for Growth in the Pharma and Regulatory Affairs.
Regulatory Affairs department is the strength of Pharmaceutical Industry. It is the revenue generator for pharmaceutical Industry. The Regulatory Affairs department is an important part of the pharmaceutical companies. More than 15 years span is required to develop and launch a new pharmaceutical product in the market. The Regulatory Affairs Agencies explains expenditure spent on each drug annually is $850 million in US. The Indian Pharmaceutical industry is one of the fastest growing industries in India, with a compounded annual growth rate (CAGR) of over 13 % in last 5 years and it is expected to grow at a higher rate in coming 10 years India spends around $300 million, united kingdom $700 million, Brazil $200 million, France $550 million, Italy $400 million. As per cabinet decision in June 2010 in Japan amended a new policy i.e., Health power strategy through “Life Innovation” and expenditure spent on each drug was $450 million. Internally it cooperates with other department like drug development, manufacturing, marketing and clinical research. Externally, it is the key interface between the company and the regulatory authorities. Industrialized regulatory affairs are to drive compliance, speed to market, and cost efficiency.
OMICS International Organises 300+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members OMICS Group Conferences make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, world class exhibitions and poster presentations.